Back to mobile site
Get it on Google Play

Labcorp launches companion diagnostic for ovarian cancer treatment

April 22, 2026 7:01 AM EDT Send to a Friend
Labcorp (NYSE: LH) announced the nationwide availability of Agilent Technologies' PD-L1 IHC 22C3 pharmDx, a companion diagnostic approved by the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login